GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lukas Biomedical Inc (ROCO:6814) » Definitions » Research & Development

Lukas Biomedical (ROCO:6814) Research & Development : NT$45.74 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Lukas Biomedical Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Lukas Biomedical's Research & Development for the six months ended in Jun. 2024 was NT$45.74 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was NT$45.74 Mil.

Lukas Biomedical Research & Development Historical Data

The historical data trend for Lukas Biomedical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lukas Biomedical Research & Development Chart

Lukas Biomedical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Research & Development
22.85 29.20 35.39 54.98 55.92

Lukas Biomedical Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 30.44 26.32 29.60 33.38 45.74

Lukas Biomedical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$45.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lukas Biomedical  (ROCO:6814) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lukas Biomedical Research & Development Related Terms

Thank you for viewing the detailed overview of Lukas Biomedical's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Lukas Biomedical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lukas Biomedical Inc (ROCO:6814) » Definitions » Research & Development
Comparable Companies
ROCO:6549 ROCO:6808 ROCO:6917 ROCO:3118 ROCO:4732 ROCO:6236 ROCO:4131 ROCO:6652 ROCO:6662 ROCO:4192 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Xinyi Road, Da'an District, 3rd Floor, No. 2, Lane 265, Section 4, Taipei, TWN
Website
https://www.lukas-bio.com.tw
Lukas Biomedical Inc is engaged in the research and development of immunotherapy for cancer treatment technologies. It researches on the Memory T cell (LuLym-T) to improve the clinical outcome of cancer treatment.

Lukas Biomedical Headlines

No Headlines